Sii
- All
- News
- Videos
- Photos
- Web Stories
-
India Introduces 2 Special Category Visas For International Students, Check Details
According to officials, to avail of the visa benefits, all applicants must use the 'Study in India' (SII) portal.
-
Serum Institute's New "High Efficacy" Malaria Vaccine Rolls Out In Africa
A new "high efficacy" malaria vaccine co-developed by the Serum Institute of India (SII) and the University of Oxford was officially rolled out on Monday when Cote d'Ivoire in West Africa became the first country to begin administering R21/Matrix-M.
-
Serum Institute Begins Shipments Of Malaria Vaccine 'R21/Matrix-M' To Africa
Vaccines manufacturer Serum Institute of India (SII) on Monday said it has started exports of 'R21/Matrix-M' malaria vaccine to Africa as part of the global fight against the disease.
-
Sharad Pawar Demands Bharat Ratna For Serum Institute Founder Cyrus Poonawalla
Praising the work done by the founder of the Serum Institute of India (SII), in the field of vaccine production, founder of Nationalist Congress Party (NCP) Sharad Pawar demanded that Cyrus Poonawalla be honoured with the Bharat Ratna award.
-
Billionaire Cyrus Poonawalla Suffers Cardiac Arrest, Stable After Angioplasty
Dr Cyrus Poonawalla, Chairman and Managing Director of the city-based vaccine manufacturer Serum Institute of India (SII), suffered mild cardiac arrest and underwent an angioplasty procedure in a hospital here, doctors said on Friday.
-
Centre Launches 'Study In India' Portal To Help International Students
Study in India Portal is a dedicated website that will provide comprehensive information about the Indian Higher Education Institutions (HEIs).
-
Current Covid Strain Mild, 5-6 Million Covovax Doses Made: Adar Poonawalla
The prevalent strain of COVID-19 is mild and the Serum Institute of India (SII) has already produced five to six million doses of the Covovax vaccine, said the company's chief executive officer Adar Poonawalla.
-
Oxford University, Serum Institute Deliver 'High Efficacy' Malaria Vaccine
A University of Oxford developed and Serum Institute of India (SII) manufactured and scaled up "high efficacy" malaria vaccine has been licensed for use in Ghana by Africa's Food and Drugs Authority, the university announced here on Thursday.
-
Serum Institute's Cervical Cancer Vaccine To Hit Market This Month: Report
The Serum Institute's made-in-India vaccine against cervical cancer, CERVAVAC, will be available in the market this month at an MRP of Rs 2,000 per vial of two doses, official sources said on Thursday.
-
China Needs "Good Covid Booster" Like Covovax, Says Adar Poonawalla
China needs a good COVID-19 booster vaccine like Covovax, but so far there hasn't been a positive response from China, said Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday.
-
India Introduces 2 Special Category Visas For International Students, Check Details
According to officials, to avail of the visa benefits, all applicants must use the 'Study in India' (SII) portal.
-
Serum Institute's New "High Efficacy" Malaria Vaccine Rolls Out In Africa
A new "high efficacy" malaria vaccine co-developed by the Serum Institute of India (SII) and the University of Oxford was officially rolled out on Monday when Cote d'Ivoire in West Africa became the first country to begin administering R21/Matrix-M.
-
Serum Institute Begins Shipments Of Malaria Vaccine 'R21/Matrix-M' To Africa
Vaccines manufacturer Serum Institute of India (SII) on Monday said it has started exports of 'R21/Matrix-M' malaria vaccine to Africa as part of the global fight against the disease.
-
Sharad Pawar Demands Bharat Ratna For Serum Institute Founder Cyrus Poonawalla
Praising the work done by the founder of the Serum Institute of India (SII), in the field of vaccine production, founder of Nationalist Congress Party (NCP) Sharad Pawar demanded that Cyrus Poonawalla be honoured with the Bharat Ratna award.
-
Billionaire Cyrus Poonawalla Suffers Cardiac Arrest, Stable After Angioplasty
Dr Cyrus Poonawalla, Chairman and Managing Director of the city-based vaccine manufacturer Serum Institute of India (SII), suffered mild cardiac arrest and underwent an angioplasty procedure in a hospital here, doctors said on Friday.
-
Centre Launches 'Study In India' Portal To Help International Students
Study in India Portal is a dedicated website that will provide comprehensive information about the Indian Higher Education Institutions (HEIs).
-
Current Covid Strain Mild, 5-6 Million Covovax Doses Made: Adar Poonawalla
The prevalent strain of COVID-19 is mild and the Serum Institute of India (SII) has already produced five to six million doses of the Covovax vaccine, said the company's chief executive officer Adar Poonawalla.
-
Oxford University, Serum Institute Deliver 'High Efficacy' Malaria Vaccine
A University of Oxford developed and Serum Institute of India (SII) manufactured and scaled up "high efficacy" malaria vaccine has been licensed for use in Ghana by Africa's Food and Drugs Authority, the university announced here on Thursday.
-
Serum Institute's Cervical Cancer Vaccine To Hit Market This Month: Report
The Serum Institute's made-in-India vaccine against cervical cancer, CERVAVAC, will be available in the market this month at an MRP of Rs 2,000 per vial of two doses, official sources said on Thursday.
-
China Needs "Good Covid Booster" Like Covovax, Says Adar Poonawalla
China needs a good COVID-19 booster vaccine like Covovax, but so far there hasn't been a positive response from China, said Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday.
